STOCK TITAN

OnKure Therapeutics: Venrock group reports 5.7% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

OnKure Therapeutics, Inc. (OKUR) has a reporting group that disclosed beneficial ownership of 2,309,559 Class A shares, or 5.7% of the class. The group comprises Venrock Healthcare Capital Partners III, L.P.; VHCP Co-Investment Holdings III, LLC; Venrock Healthcare Capital Partners EG, L.P.; VHCP Management III, LLC; VHCP Management EG, LLC; Nimish P. Shah; and Bong Y. Koh.

The reporting persons show shared voting and dispositive power over 2,309,559 shares. The 5.7% figure is based on 40,503,094 Class A shares outstanding as of November 2, 2026.

Beneficial ownership 2,309,559 shares Aggregate reported by each reporting person for Class A common stock
Percentage of class 5.7% Reported beneficial ownership
Class A shares outstanding 40,503,094 shares As of November 2, 2026
VHCP III holdings 1,049,696 shares Class A shares held by Venrock Healthcare Capital Partners III, L.P.
VHCP Co-Investment III holdings 105,087 shares Class A shares held by VHCP Co-Investment Holdings III, LLC
VHCP EG holdings 1,154,776 shares Class A shares held by Venrock Healthcare Capital Partners EG, L.P.
beneficially owned financial
"aggregate number of shares ... beneficially owned by such Reporting Person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power regulatory
"Shared Voting Power 2,309,559.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared Dispositive Power 2,309,559.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many OKUR shares does the reporting group beneficially own?

The group disclosed 2,309,559 Class A shares as beneficially owned, representing 5.7% of the class.

Which entities hold the OKUR Class A shares in the reported stake?

Three entities are identified: 1,049,696 shares held by Venrock Healthcare Capital Partners III, L.P.; 105,087 by VHCP Co-Investment Holdings III, LLC; and 1,154,776 by Venrock Healthcare Capital Partners EG, L.P.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





68277Q105

(CUSIP Number)
11/13/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Venrock Healthcare Capital Partners III, L.P.
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management III, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
Date:11/20/2026
VHCP Co-Investment Holdings III, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management III, LLC, its Manager, By Sherman G. Souther, Authorized Signatory
Date:11/20/2026
Venrock Healthcare Capital Partners EG, L.P.
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management EG, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
Date:11/20/2026
VHCP Management III, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Authorized Signatory
Date:11/20/2026
VHCP Management EG, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Authorized Signatory
Date:11/20/2026
Nimish Shah
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Attorney-in-fact
Date:11/20/2026
Bong Y. Koh
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Attorney-in-fact
Date:11/20/2026
Exhibit Information

Exhibit 24.1 Power of Attorney for Bong Y. Koh Exhibit 24.2 Power of Attorney for Nimish P. Shah Exhibit 99.1 Joint Filing Agreement

Keep reading